Questor Technology (QST) investor relations material

Executive summary

• Q2 revenue fell to $0.2M from $3.0M YoY; gross loss was $0.3M and Adjusted EBITDA loss was $0.5M, reflecting delayed international sales and low rental-fleet utilization.

• Phase III plan prioritizes North American fleet deployment, contracted international work, and an evidence-based decision on the ORC program; 2027 and 2029 revenue targets are $10M and $15M.

Financial highlights

• Q2 revenue was $239,880 vs. $3.0M in Q2 2025; H1 revenue was $739,188 vs. $5.4M.

• Q2 gross loss was $260,139 vs. $1.6M gross profit YoY; H1 gross loss was $204,187 vs. $2.8M gross profit.

• Q2 Adjusted EBITDA was negative $535,896 vs. positive $871,374; H1 was negative $358,035 vs. positive $1.35M.

• Q2 net loss was $780,287, or $0.028 per share, vs. net income of $363,147, or $0.013 per share; H1 net loss was $894,991, or $0.032 per share.

• Adjusted EBITDA included $1.4M of Emission Rx litigation cash recoveries and $0.2M NRC recovery recorded as a reduction of R&D expense; legal and professional fees also increased.

Outlook and guidance

• Revenue targets are $10M in 2027 and $15M in 2029, from rentals, service and parts, and equipment sales and installations; targets predate and exclude the proposed Emission Rx acquisition.

• Near-term priorities include redeploying fleet under North American contracts, advancing international backlog as conditions allow, and fulfilling anticipated international purchase orders.

• ORC commercialization decision expected in Q3 2026, following an independent review of technical readiness, development needs, capital requirements, market opportunity, and returns.

• Iraq commissioning shifted to Q3 2026 due to schedule slippage amid Middle East conflict; completion remains dependent on regional conditions.